The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Glossary
magnesium valproate
The magnesium salt of valproic acid (2-propylpentanoic acid) with
antiepileptic and potential antineoplastic activities. Magnesium
valproate dissociates in the gastrointestinal tract and is absorbed
into the circulation as magnesium ions and valproic acid ions; valproic
acid may inhibit histone deacetylases, inducing tumor cell
differentiation, apoptosis, and growth arrest. In addition, valproic
acid exerts an antiepileptic effect, likely by inhibiting enzymes that
catabolize the inhibitory neurotransmitter gamma-aminobutyric acid
(GABA) catabolism and so increasing concentrations of GABA in the
central nervous system (CNS). The presence of the magnesium in this
agent may contribute to its anticonvulsant activity and sedative
properties.